The global osteoporosis drugs market size was valued at USD 14.90 billion in 2024 and is projected to reach USD 15.39 billion in 2025 and USD 19.96 billion by 2033, growing at a CAGR of 3.3% during the forecast period (2025-2033). The growth of the market is attributed to the rising prevalence of osteoporosis and the adoption of a sedentary lifestyle.